| Q35752526 | A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma |
| Q35600362 | Arsenic, cadmium and neuron specific enolase (ENO2, γ-enolase) expression in breast cancer. |
| Q38749116 | Breast Carcinoma With Unrecognized Neuroendocrine Differentiation Metastasizing to the Pancreas: A Potential Diagnostic Pitfall |
| Q37551363 | Breast carcinoma--rare types: review of the literature |
| Q37121911 | CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer |
| Q48105836 | Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast. |
| Q36738871 | Doublecortin-like kinase 1 expression associates with breast cancer with neuroendocrine differentiation |
| Q35075805 | Fine-needle aspiration detects primary neuroendocrine carcinoma of the breast in a patient with breast implants |
| Q38019842 | HER-2 positive primary solid neuroendocrine carcinoma of the breast: a case report and review of the literature. |
| Q38706578 | High-grade poorly differentiated neuroendocrine carcinoma of the breast with low oncotype Dx recurrence score: A case report. |
| Q33454999 | Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis |
| Q37888739 | Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges |
| Q51765780 | Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma. |
| Q35109569 | Invasive neuroendocrine carcinoma of the breast: a population-based study from the surveillance, epidemiology and end results (SEER) database |
| Q36929973 | Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature |
| Q38440364 | MDM2 protein expression is a negative prognostic marker in breast carcinoma. |
| Q38099586 | Metastases from neuroendocrine tumors to the breast are more common than previously thought. A diagnostic pitfall? |
| Q84295079 | Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type |
| Q57369976 | NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis |
| Q38169781 | Neuroendocrine carcinoma of the breast - a pilot study of a Danish population of 240 breast cancer patients |
| Q45767913 | Neuroendocrine differentiation correlates with hormone receptor expression and decreased survival in patients with invasive breast carcinoma |
| Q52934867 | Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome. |
| Q48585560 | Neuroendocrine neoplasms of the breast |
| Q34029911 | Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide |
| Q38213176 | Papillary and neuroendocrine breast lesions: the WHO stance |
| Q37770470 | Pitfalls in pulmonary cytopathology |
| Q39007394 | Primary Neuroendocrine Carcinoma of the Breast: Histopathological Criteria, Prognostic Factors, and Review of the Literature |
| Q37998934 | Primary neuroendocrine breast cancer, how much do we know so far? |
| Q37603679 | Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature |
| Q51754489 | Prognostic importance of neuroendocrine differentiation in Japanese breast cancer patients |
| Q39989109 | Quantitative assessment of tissue biomarkers and construction of a model to predict outcome in breast cancer using multiple imputation |
| Q34161862 | Search for neuro-endocrine markers (chromogranin A, synaptophysin and VGF) in breast cancers. An integrated approach using immunohistochemistry and gene expression profiling |
| Q30445932 | Solid neuroendocrine breast carcinoma: mammographic and sonographic features in thirteen cases |
| Q42876197 | Solid neuroendocrine carcinomas of the breast: metastases or primary tumors? |
| Q38991996 | The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer |
| Q36666413 | The extended granin family: structure, function, and biomedical implications |
| Q36620486 | The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumours: a comment on concepts and classification of mixed exocrine-endocrine neoplasms |
| Q46661732 | Tissue microarray analysis as a screening tool for neuroendocrine carcinoma of the breast |
| Q90065925 | Voltage gated sodium channels in cancer and their potential mechanisms of action |
| Q83878452 | [Mixed endocrine tumors] |